I Tried to Build a Week-by-Week Muscle-Peptide Timeline. The Research Wouldn’t Let Me.

Here’s the promise you’ve probably seen if you’ve spent any time in a supplement forum or scrolled past the wrong ad. Week two, you sleep better and bounce back from workouts faster. Week four, your pumps at the gym go through the roof. Week eight, you can see new muscle in the mirror. Week twelve, people start asking questions. It reads like a training calendar, printed with total confidence, down to the week.

I wanted to know where that calendar came from. So I did the boring thing: I went and read the actual studies behind these compounds, the ones people call “peptides for muscle growth,” things like MK-677, ipamorelin, CJC-1295, follistatin 344, hexarelin, GHRP-6, and IGF-1 LR3. I wanted to build my own honest version of that timeline.

I couldn’t. Not because the research is hiding somewhere I didn’t look, but because the confident week-by-week chart is mostly not backed by anything. What I found instead was smaller, slower, and a lot more useful. Let me walk you through it the way I’d explain it to a friend at the kitchen table.

One thing up front, because it matters: most of these compounds are not FDA-approved for building muscle, the human evidence on them is thin, and the whole category is banned in tested sports. I’m not telling you what to do here. I’m telling you what the evidence actually says once you stop borrowing numbers from a sales page.

What these things actually are

Quick definitions, since none of this makes sense without them. Most of these compounds aren’t muscle itself, they’re signals that try to get your body to make more growth hormone, which then triggers your liver to make more IGF-1, a hormone closely tied to tissue growth. Think of it like a doorbell. Ringing the doorbell isn’t the same as someone actually walking through the door and doing the work inside the house. CJC-1295, ipamorelin, hexarelin, and GHRP-6 are all, in different ways, doorbells for growth hormone. MK-677 does something similar through a pill instead of a shot. Follistatin 344 works differently, it’s aimed at blocking a protein called myostatin that normally puts brakes on muscle growth, so removing the brake is supposed to let the engine rev higher.

Ringing the bell is easy to measure. Whether the person inside actually rebuilds the house is a much harder, slower question. That gap turned out to be the whole story.

The doorbell rings fast. The remodeling happens slow, if it happens at all.

This is the part that actually gets people, so let’s slow down here.

If you take CJC-1295, your growth hormone really does jump, and fast. In a controlled study of healthy adults, a single dose raised growth hormone two- to ten-fold for six days or longer, and IGF-1 climbed one-and-a-half to three-fold for nine to eleven days, staying above baseline for up to 28 days with repeated dosing [2]. Hexarelin works even quicker: an intravenous dose in healthy volunteers produced roughly double the growth hormone release you’d get from the body’s own releasing hormone [3]. Ipamorelin reliably does the same job, cleanly, which is exactly what it was designed to do [4].

So if you start one of these and within a couple of weeks you’re sleeping harder, recovering quicker, or eating more, that’s not in your head. Your hormones genuinely shifted. The doorbell rang.

Here’s the trap, though. People treat that fast, real signal as proof that muscle is already on its way, like hearing the doorbell means the guest has already unpacked their bags. But the studies measuring the doorbell and the studies measuring actual muscle built over time are two completely different bodies of research, and for most of these compounds, the second one barely exists in humans at all.

The one study that actually waited long enough to check

If you want to know how long it takes to see real muscle, you need a study that ran long enough and measured the right thing. There’s exactly one candidate in this entire category that fits that description, and it’s about MK-677.

Researchers ran a two-year randomized, placebo-controlled trial in healthy older adults [1]. Two years, not two weeks. Over that stretch, the MK-677 group gained roughly 1.1 kg of fat-free mass, while the placebo group actually lost about half a kilo [1]. So yes, given a genuinely long runway, the best-studied compound in this whole space moved the needle a little.

But here’s the sentence that stopped me cold, the one that never makes it onto the hype charts: that extra fat-free mass “did not result in changes in strength or function” [1]. Two years. A small win on the scale. Zero measurable improvement in how strong or capable the person actually was. And keep in mind, “fat-free mass” includes water and connective tissue, not just contractile muscle, so even that kilo-ish gain is softer than it sounds.

Now put the two timelines side by side. The forum chart promises visible muscle by week eight. The best real trial we have used a two-year window and found about a kilo of lean mass with no strength benefit at all. Those aren’t just different numbers. They’re different planets, and only one of them has actual data holding it up.

The follistatin mix-up (this one trips up a lot of people)

Follistatin 344 deserves its own little detour, because its reputation is the most borrowed and least earned of the bunch.

People talk about it like it’s a shortcut to dramatic muscle, and that idea comes from animal research, where blocking myostatin really does produce big gains in mice. But when you look for the human data, what actually exists is a gene therapy trial. Researchers injected a follistatin gene therapy construct directly into the thigh muscles of patients with Becker muscular dystrophy, a muscle-wasting disease, and tracked them over the following months. Some patients walked farther, and muscle growth showed up on biopsy [6].

That’s a genuinely interesting result. But notice what it is: gene therapy, injected straight into specific muscles, in sick patients, followed for months in a small early trial. That’s like reading about a heart transplant and assuming a daily vitamin will do the same job. It is not a preview of what happens when a healthy person injects a follistatin peptide hoping their arms will grow. If anyone shows you a follistatin “results by week X” chart, they built it out of thin air, because the human evidence simply doesn’t contain it.

What to actually expect, stage by stage

Early days to a few weeks: expect the hormone shifts to be real. Sleep, recovery, appetite, these can genuinely change fast on a growth hormone releaser [2][3]. Just don’t read that as evidence that muscle is coming. It’s the doorbell, not the guest.

A few weeks to a few months: the honest answer is “nobody really knows,” because studies actually tracking muscle over this window in healthy adults mostly don’t exist for these compounds. Anyone giving you a precise figure here is guessing. What you’ll most likely notice is subtle stuff that’s hard to separate from your training and diet, which you’d presumably be doing anyway.

Many months to years: expect modest results at best, and expect the scale to fib to you a little. The one long, careful trial we have shows about a kilo of lean mass over two years with no strength gain [1]. If that’s the best case, from the best-studied option, it’s reasonable to expect less, not more, from the less-studied ones.

The meter that’s running the whole time

Here’s the thing the optimistic timelines never mention: while you’re waiting on muscle that may never really show up, something else is quietly accumulating in the background.

These compounds push up the IGF-1 system, and in a prospective study following 394,388 people, higher circulating IGF-1 was linked to increased risk of several cancers, including breast and prostate [5]. That’s not something you’d feel at week eight. It’s a slow-building exposure question, running underneath the whole “am I getting muscle yet” conversation. So the real timeline isn’t just “when do I see results.” It’s “how long am I sitting with elevated IGF-1 chasing a payoff the evidence says is small.” Framed honestly, that changes the math quite a bit.

And if you’re in a tested sport, there’s no timeline at all to discuss. Growth hormone secretagogues, IGF-1, and their analogues are on the WADA Prohibited List, banned at all times, in or out of competition, no matter the dose or how you take them [7]. For an athlete, the clock just says “banned,” full stop.

What I’d actually tell a friend

If a friend asked me to sketch the real muscle-peptide timeline after all this reading, here’s the short version I’d hand over.

The hormone effects are real and quick, and they’ll trick you into thinking muscle is right behind them. The muscle itself, on the best evidence we have, is slow, modest, and in the one serious long-term trial, didn’t even translate into strength [1]. Most of these compounds don’t have real human muscle data at all, just hormone-release studies wearing a muscle-growth costume [2][3][4]. Follistatin’s only human evidence is gene therapy in sick patients, not a gym schedule [6]. And the whole time you’re waiting, there’s an IGF-1 cancer-risk question running in the background [5], plus a flat ban if you compete [7].

That’s not the timeline anyone’s selling you. It’s the one the evidence actually supports, and I’d rather hand a friend that honest, unglamorous version than the confident fake one.

If someone reads all of that and still wants to explore it, the only version of this worth doing is a supervised one, where a clinician sets expectations honestly, checks your IGF-1 risk, and actually watches what’s happening instead of letting you chase a chart you found online. As one example of that kind of setup, FormBlends offers physician-reviewed, prescription access through licensed compounding pharmacies, and is upfront that these are not FDA-approved finished drugs and not proven muscle builders. The name isn’t the point. The point is that the honest timeline and the supervised path turn out to be the same answer, just wearing two different hats.

Questions people keep asking me about this

Why do those detailed week-by-week timelines look so specific if the research doesn’t back them up? Because they’re built by treating a fast hormone change as if it were a muscle change. Most human studies on these compounds measure growth hormone and IGF-1 levels, not muscle gained over time, so the “week four, week eight, week twelve” charts are extrapolated from how someone feels, not from before-and-after muscle measurements. The specificity is a storytelling choice, not a research finding.

How fast do these things actually do anything you could measure? Fast, on the hormone side. A single dose of CJC-1295 raised growth hormone two- to ten-fold for six days or more and kept IGF-1 elevated for over a week, staying above baseline for up to 28 days with repeated dosing [2]. Hexarelin and ipamorelin also reliably trigger growth hormone release [3][4]. So within days to weeks your hormones shift, which is exactly why the early “this is working” feeling isn’t fake, even when the muscle isn’t following behind it.

How long does it really take to build actual muscle with these? Slowly, and modestly, if at all, based on what we actually have. The strongest study is a two-year randomized, placebo-controlled trial of MK-677 in healthy older adults, which found about 1.1 kg of fat-free mass gained over two years, a gain that “did not result in changes in strength or function” [1]. For the less-studied compounds, there’s essentially no human data tracking muscle over time, so any precise timeline for them is invented.

Is follistatin 344 a shortcut to faster muscle? No, that reputation comes from animal research. The only human data is a gene therapy trial that injected a follistatin construct directly into the thigh muscles of Becker muscular dystrophy patients and followed them for months [6]. That’s sick patients, localized gene therapy, and a small early-phase trial, not a preview of what a healthy person injecting a follistatin peptide would experience.

If the muscle gains are this modest, what’s the actual cost of waiting around for them? The IGF-1 exposure clock keeps running the whole time. A prospective study of 394,388 people found that higher circulating IGF-1 was linked to increased risk of several cancers, including breast and prostate [5]. Spending months or years pushing that axis for a modest payoff means the honest question isn’t just “when will I see muscle,” it’s “how long am I sitting in an elevated-IGF-1 state to get there.”

Can I use these if I compete in a tested sport? No. Growth hormone secretagogues and related peptides, including MK-677, ipamorelin, hexarelin, and the GHRPs, along with IGF-1 and its analogues, sit on the WADA Prohibited List and are banned at all times, in and out of competition, regardless of dose or route [7]. If you’re a tested athlete, there’s no timeline to plan around here, just a positive test waiting to happen.

References

1. Nass R, Pezzoli SS, Oliveri MC, et al. “Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.” Ann Intern Med. 2008;149(9):601-611. PMID 18981485. https://pubmed.ncbi.nlm.nih.gov/18981485/
2. Teichman SL, Neale A, Lawrence B, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.” J Clin Endocrinol Metab. 2006;91(3):799-805. PMID 16352683. https://pubmed.ncbi.nlm.nih.gov/16352683/
3. Ghigo E, Arvat E, Gianotti L, et al. “Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.” J Clin Endocrinol Metab. 1994;78(3):693-698. PMID 8126144.
4. Raun K, Hansen BS, Johansen NL, et al. “Ipamorelin, the first selective growth hormone secretagogue.” Eur J Endocrinol. 1998;139(5):552-561. PMID 9849822.
5. Knuppel A, Fensom GK, Watts EL, et al. “Circulating Insulin-like Growth Factor-I Concentrations and Risk of 30 Cancers: Prospective Analyses in UK Biobank.” Cancer Res. 2020;80(18):4014-4021. PMID 32709735.
6. Mendell JR, Sahenk Z, Malik V, et al. “A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.” Mol Ther. 2015;23(1):192-201. PMID 25322757.
7. WADA Prohibited List S2, peptide hormones, growth factors and related substances (lists ibutamoren/MK-677, ipamorelin, hexarelin/GHRPs, IGF-1 and analogues, prohibited at all times).

So what are these “peptides for muscle growth” in plain terms?

They’re short chains of amino acids that act as chemical messages, telling your body to release more growth hormone or nudge repair processes in muscle tissue. The ones you hear about most, CJC-1295, ipamorelin, and BPC-157, work by tugging on your own hormone system rather than dumping synthetic hormone straight in. Think of them as messengers knocking on a door, not movers carrying furniture in. The research is still early, most human trials are small, and the full picture isn’t written yet.

Are they actually safe to use?

That depends a lot on what you’re taking, where it came from, and whether a doctor is involved at all. Anything bought from an unregulated research-chemical website carries real contamination and dosing risk, because nobody’s checking the work. The human trials we do have on growth hormone secretagogues generally show mild side effects at the doses studied, but the long-term picture is thin. Going through a physician-supervised compounding pharmacy, like FormBlends, adds a layer of accountability that ordering from a random site online simply doesn’t have.

Which of these have the strongest evidence behind them?

Ipamorelin and CJC-1295 together are probably the most studied combination for raising growth hormone pulses with a fairly clean short-term safety record. BPC-157 gets a lot of buzz for tissue repair, but nearly all of that comes from rodent studies, not people. MK-677 isn’t technically a peptide, but it hits the same receptor and has more human data behind it than most of the others. Calling anything on this list definitively “the best” claims more certainty than the evidence actually offers.

Realistically, how long before I’d notice muscle results?

People following supervised protocols tend to describe changes in recovery and body composition somewhere in the eight-to-sixteen-week range, not the two-to-four-week timelines you see hyped around online. Growth hormone pathways move slowly by design, and things like training, sleep, and diet do more heavy lifting than the peptide itself. If someone promises dramatic muscle in a month, they’re describing a timeline the biology just doesn’t support.